1	Britain	britain	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG;18:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	rejected	reject	VBN	pb=reject.01	0	root	_
6	a	a	DT	_	12	det	_
7	sweetened	sweeten	VBN	pb=sweeten.02	12	amod	_
8	'	'	``	p2=''	12	punct	_
9	final	final	JJ	_	12	amod	_
10	'	'	''	_	12	punct	_
11	buyout	buyout	NN	p2=VBN	12	nn	_
12	offer	offer	NN	p2=VBP	5	dobj	5:A1=PPT;7:A1=PPT
13	from	from	IN	_	12	prep	_
14	US	us	NNP	_	15	nn	_
15	drugmaker	drugmaker	NN	p2=NNP	16	nn	_
16	Pfizer	pfizer	NNP	p2=NN	13	pobj	_
17	,	,	,	_	5	punct	_
18	putting	put	VBG	pb=put.01	5	advcl	_
19	into	into	IN	_	18	prep	18:A2=GOL
20	question	question	NN	_	21	nn	_
21	Pfizer	pfizer	NNP	p2=NN	23	poss	_
22	's	's	POS	_	21	possessive	_
23	plan	plan	NN	_	19	pobj	_
24	to	to	TO	_	25	aux	_
25	create	create	VB	pb=create.01	23	infmod	_
26	the	the	DT	_	27	det	_
27	world	world	NN	_	31	poss	_
28	's	's	POS	_	27	possessive	_
29	biggest	big	JJS	_	31	amod	_
30	pharmaceuticals	pharmaceutical	NNS	_	31	nn	_
31	group	group	NN	_	25	dobj	25:A1=PPT
32	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	Sunday	sunday	NNP	_	2	npadvmod	2:AM-TMP
4	it	it	PRP	_	6	nsubj	6:A0=PAG
5	was	be	VBD	_	6	aux	_
6	raising	raise	VBG	pb=raise.01	2	ccomp	2:A1=PPT
7	its	its	PRP$	_	9	poss	_
8	takeover	takeover	NN	_	9	nn	_
9	offer	offer	NN	p2=VB	6	dobj	6:A1=PPT
10	to	to	IN	_	6	prep	6:A4=GOL
11	55	0	CD	_	12	num	_
12	pounds	pound	NNS	_	10	pobj	_
13	a	a	DT	_	14	det	_
14	share	share	NN	_	12	npadvmod	_
15	,	,	,	_	12	punct	_
16	or	or	CC	_	12	cc	_
17	69	0	CD	_	18	number	_
18	billion	#crd#	CD	_	19	num	_
19	pounds	pound	NNS	_	12	conj	_
20	(	(	-LRB-	_	19	punct	_
21	$	$	$	_	23	quantmod	_
22	118	0	CD	_	23	number	_
23	billion	#crd#	CD	_	19	appos	_
24	,	,	,	_	19	punct	_
25	86	0	CD	_	26	number	_
26	billion	#crd#	CD	_	27	num	_
27	euros	euro	NNS	_	19	appos	_
28	)	)	-RRB-	_	19	punct	_
29	in	in	IN	_	6	prep	_
30	total	total	NN	p2=JJ	29	pobj	_
31	,	,	,	_	6	punct	_
32	of	of	IN	_	23	prep	_
33	which	which	WDT	_	32	pobj	_
34	45	0	CD	_	35	num	_
35	percent	percent	NN	_	37	nsubj	37:A1=PPT
36	would	would	MD	_	37	aux	37:AM-MOD
37	be	be	VB	pb=be.01	6	advcl	_
38	in	in	IN	_	37	prep	37:A2=PRD
39	cash	cash	NN	_	38	pobj	_
40	and	and	CC	_	39	cc	_
41	the	the	DT	_	42	det	_
42	balance	balance	NN	_	39	conj	_
43	in	in	IN	_	42	prep	_
44	shares	share	NNS	_	43	pobj	_
45	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	5	nsubj	5:A0=PPT
4	would	would	MD	_	5	aux	5:AM-MOD
5	walk	walk	VB	pb=walk.01	2	ccomp	2:A1=PPT
6	away	away	RB	_	5	advmod	5:AM-DIR
7	if	if	IN	_	9	mark	_
8	AstraZeneca	astrazeneca	NNP	_	9	nsubj	9:A0=PAG
9	rejected	reject	VBD	pb=reject.01	5	advcl	5:AM-ADV
10	the	the	DT	_	12	det	_
11	latest	late	JJS	_	12	amod	_
12	offer	offer	NN	_	9	dobj	9:A1=PPT
13	.	.	.	_	2	punct	_

1	On	on	IN	_	10	prep	10:AM-TMP
2	Monday	monday	NNP	_	1	pobj	_
3	,	,	,	_	10	punct	_
4	just	just	RB	_	5	advmod	_
5	nine	#crd#	CD	_	6	num	_
6	hours	hour	NNS	_	7	npadvmod	_
7	later	later	RB	_	10	advmod	10:AM-TMP
8	,	,	,	_	10	punct	_
9	AstraZeneca	astrazeneca	NNP	_	10	nsubj	10:A0
10	said	say	VBD	pb=say.01	0	root	_
11	no.	no.	NN	p2=``	12	nn	_
12	A	a	NNP	p2=DT	13	nsubj	13:A1=PPT
13	merged	merge	VBD	pb=merge.01	10	ccomp	10:A1=PPT
14	Pfizer	pfizer	NNP	p2=NN	16	hmod	_
15	-	-	HYPH	p2=:	16	hyph	_
16	AstaZeneca	astazeneca	NNP	_	19	nsubj	19:A0=PAG
17	would	would	MD	_	19	aux	19:AM-MOD
18	have	have	VB	_	19	aux	_
19	had	have	VBN	pb=have.03	13	ccomp	_
20	its	its	PRP$	_	21	poss	_
21	headquarters	headquarters	NN	p2=NNS	19	dobj	19:A1=PPT
22	in	in	IN	_	21	prep	_
23	New	new	NNP	_	24	nn	_
24	York	york	NNP	_	22	pobj	_
25	,	,	,	_	19	punct	_
26	but	but	CC	_	19	cc	_
27	its	its	PRP$	_	29	poss	_
28	tax	tax	NN	_	29	nn	_
29	base	base	NN	_	13	conj	_
30	in	in	IN	_	29	prep	_
31	Britain	britain	NNP	_	30	pobj	37:AM-LOC
32	,	,	,	_	31	punct	_
33	where	where	WRB	_	37	advmod	37:R-AM-LOC
34	corporate	corporate	JJ	_	36	amod	_
35	tax	tax	NN	_	36	nn	_
36	rates	rate	NNS	_	37	nsubj	37:A1=PPT
37	are	be	VBP	pb=be.01	31	rcmod	_
38	lower	low	JJR	_	37	acomp	37:A2=PRD
39	than	than	IN	_	38	prep	_
40	in	in	IN	_	39	prep	_
41	the	the	DT	_	43	det	_
42	United	united	NNP	_	43	nn	_
43	States	states	NNP	_	40	pobj	_
44	.	.	.	_	10	punct	_

1	Pfizer	pfizer	NNP	_	4	poss	_
2	's	's	POS	_	1	possessive	_
3	proposed	propose	VBN	p2=JJ|pb=propose.01	4	amod	_
4	takeover	takeover	NN	_	8	nsubj	3:A1=PPT;8:A1=PPT
5	of	of	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	would	would	MD	_	8	aux	8:AM-MOD
8	be	be	VB	pb=be.01	0	root	_
9	the	the	DT	_	14	det	_
10	largest	large	JJS	p2=RBS	12	hmod	_
11	-	-	HYPH	p2=,	12	hyph	_
12	ever	ever	RB	_	14	amod	_
13	foreign	foreign	JJ	_	14	amod	_
14	acquisition	acquisition	NN	_	8	attr	8:A2=PRD
15	of	of	IN	_	14	prep	_
16	a	a	DT	_	18	det	_
17	British	british	JJ	_	18	amod	_
18	company	company	NN	_	15	pobj	_
19	.	.	.	_	8	punct	_

1	Many	many	JJ	_	3	amod	_
2	British	british	JJ	_	3	amod	_
3	scientists	scientist	NNS	_	6	nsubj	6:A0=PAG
4	and	and	CC	_	3	cc	_
5	politicians	politician	NNS	_	3	conj	_
6	worry	worry	VBP	pb=worry.01	0	root	_
7	it	it	PRP	_	9	nsubj	9:A0=PAG
8	would	would	MD	_	9	aux	9:AM-MOD
9	undermine	undermine	VB	pb=undermine.01	6	ccomp	6:A1=PPT
10	Britain	britain	NNP	_	13	poss	_
11	's	's	POS	_	10	possessive	_
12	science	science	NN	_	13	nn	_
13	base	base	NN	_	9	dobj	9:A1=PPT
14	.	.	.	_	6	punct	_

1	At	at	IN	_	14	prep	14:AM-LOC
2	a	a	DT	_	4	det	_
3	parliamentary	parliamentary	JJ	_	4	amod	_
4	hearing	hearing	NN	_	1	pobj	_
5	in	in	IN	_	4	prep	_
6	Britain	britain	NNP	_	5	pobj	_
7	last	last	JJ	_	8	amod	_
8	week	week	NN	_	14	npadvmod	14:AM-TMP
9	,	,	,	_	14	punct	_
10	Pfizer	pfizer	NNP	_	13	nn	_
11	CEO	ceo	NNP	p2=NN	13	nn	_
12	Ian	ian	NNP	_	13	nn	_
13	Read	read	NNP	_	14	nsubj	14:A0=PAG
14	admitted	admit	VBD	pb=admit.01	0	root	_
15	that	that	IN	p2=DT	24	complm	_
16	job	job	NN	_	17	nn	_
17	cuts	cut	NNS	_	24	nsubj	24:A1=PPT
18	and	and	CC	_	17	cc	_
19	cuts	cut	NNS	p2=VBZ	17	conj	_
20	in	in	IN	_	19	prep	_
21	R&D	r&d	NN	p2=NNP	22	nn	_
22	spending	spending	NN	_	20	pobj	_
23	would	would	MD	_	24	aux	24:AM-MOD
24	occur	occur	VB	pb=occur.01	14	ccomp	14:A1
25	'	'	``	_	24	punct	_
26	somewhere	somewhere	RB	p2=NN	24	advmod	24:AM-TMP
27	'	'	''	_	24	punct	_
28	after	after	IN	_	24	prep	24:AM-TMP
29	a	a	DT	_	30	det	_
30	merger	merger	NN	_	28	pobj	_
31	.	.	.	_	14	punct	_

1	Opposition	opposition	NN	_	8	nsubj	8:A1=PPT
2	to	to	IN	_	1	prep	_
3	the	the	DT	_	5	det	_
4	proposed	propose	VBN	pb=propose.01	5	amod	_
5	deal	deal	NN	_	2	pobj	4:A1=PPT
6	has	have	VBZ	_	8	aux	_
7	also	also	RB	_	8	advmod	8:AM-ADV
8	been	be	VBN	pb=be.01	0	root	_
9	strong	strong	JJ	p2=RB	8	acomp	8:A2=PRD
10	in	in	IN	_	9	prep	_
11	Sweden	sweden	NNP	_	10	pobj	15:AM-LOC
12	,	,	,	_	11	punct	_
13	where	where	WRB	_	15	advmod	15:R-AM-LOC
14	AstraZeneca	astrazeneca	NNP	_	15	nsubj	15:A0=PAG
15	has	have	VBZ	pb=have.03	11	rcmod	_
16	half	half	PDT	p2=VBN	18	predet	_
17	its	its	PRP$	_	18	poss	_
18	roots	root	NNS	_	15	dobj	15:A1=PPT
19	.	.	.	_	8	punct	_

1	The	the	DT	_	3	det	_
2	Swedish	swedish	JJ	_	3	amod	_
3	government	government	NN	_	4	nsubj	4:A0=PAG
4	launched	launch	VBD	pb=launch.01	0	root	_
5	a	a	DT	_	7	det	_
6	concerted	concerted	JJ	_	7	amod	_
7	effort	effort	NN	_	4	dobj	4:A1=PPT
8	on	on	IN	_	4	prep	4:AM-TMP
9	Friday	friday	NNP	_	8	pobj	_
10	against	against	IN	_	4	prep	_
11	a	a	DT	_	12	det	_
12	merger	merger	NN	_	10	pobj	16:A1=PPT
13	it	it	PRP	_	14	nsubj	14:A0=PAG
14	worries	worry	VBZ	p2=NNS|pb=worry.01	12	rcmod	_
15	would	would	MD	_	16	aux	16:AM-MOD
16	lead	lead	VB	pb=lead.02	14	ccomp	14:A1=PPT
17	to	to	IN	_	16	prep	16:AM-ADV
18	cuts	cut	NNS	_	17	pobj	_
19	in	in	IN	_	18	prep	_
20	science	science	NN	_	21	nn	_
21	jobs	job	NNS	_	19	pobj	_
22	and	and	CC	_	21	cc	_
23	research	research	NN	_	21	conj	_
24	.	.	.	_	4	punct	_

1	There	there	EX	_	4	expl	_
2	has	have	VBZ	_	4	aux	_
3	also	also	RB	_	4	advmod	4:AM-ADV
4	been	be	VBN	pb=be.02	0	root	_
5	opposition	opposition	NN	_	4	attr	4:A1=PPT
6	to	to	IN	_	5	prep	_
7	the	the	DT	_	8	det	_
8	merger	merger	NN	_	6	pobj	_
9	in	in	IN	_	8	prep	_
10	US	us	NNP	_	11	nn	_
11	states	state	NNS	p2=VBZ	9	pobj	14:AM-LOC
12	where	where	WRB	_	14	advmod	14:R-AM-LOC
13	AstraZeneca	astrazeneca	NNP	_	14	nsubj	14:A0=PAG
14	has	have	VBZ	pb=have.03	11	rcmod	_
15	a	a	DT	_	17	det	_
16	big	big	JJ	_	17	amod	_
17	presence	presence	NN	_	14	dobj	14:A1=PPT
18	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nn	_
2	Chairman	chairman	NNP	_	3	nn	_
3	Leif	leif	NNP	_	5	nsubj	5:A0=PAG
4	had	have	VBD	_	5	aux	_
5	questioned	question	VBN	pb=question.01	0	root	_
6	the	the	DT	_	7	det	_
7	logic	logic	NN	_	5	dobj	5:A1=PPT
8	behind	behind	IN	_	7	prep	_
9	Pfizer	pfizer	NNP	p2=NN	11	poss	_
10	's	's	POS	_	9	possessive	_
11	move	move	NN	_	8	pobj	_
12	.	.	.	_	5	punct	_

1	"	"	``	_	10	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	approach	approach	NN	_	10	nsubj	10:A1=PPT;15:A1=PPT
5	throughout	throughout	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	pursuit	pursuit	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	appears	appear	VBZ	pb=appear.02	33	ccomp	33:A1=PPT
11	to	to	TO	_	15	aux	_
12	have	have	VB	_	15	aux	_
13	been	be	VBN	_	15	auxpass	_
14	fundamentally	fundamentally	RB	_	15	advmod	15:AM-MNR
15	driven	drive	VBN	pb=drive.02	10	xcomp	10:C-A1
16	by	by	IN	_	15	agent	15:A0=PAG
17	the	the	DT	_	20	det	_
18	corporate	corporate	JJ	_	20	amod	_
19	financial	financial	JJ	_	20	amod	_
20	benefits	benefit	NNS	_	16	pobj	_
21	to	to	IN	_	20	prep	_
22	its	its	PRP$	_	23	poss	_
23	shareholders	shareholder	NNS	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	cost	cost	NN	p2=JJ	26	nn	_
26	savings	saving	NNS	_	24	pobj	_
27	and	and	CC	_	26	cc	_
28	tax	tax	NN	_	29	nn	_
29	minimization	minimization	NN	_	26	conj	_
30	,	,	,	_	33	punct	_
31	"	"	''	p2=``	33	punct	_
32	Johansson	johansson	NNP	_	33	nsubj	33:A0
33	said	say	VBD	pb=say.01	0	root	_
34	.	.	.	_	33	punct	_

1	"	"	``	p2=''	25	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	0	root	_
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	.	.	.	_	25	punct	_
37	"	"	''	_	25	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;14:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	laid	lay	VBN	pb=lay.01	0	root	_
4	out	out	RP	_	3	prt	3:C-V
5	details	detail	NNS	_	3	dobj	3:A1=PPT
6	of	of	IN	_	5	prep	_
7	its	its	PRP$	_	8	poss	_
8	pipeline	pipeline	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	new	new	JJ	_	11	amod	_
11	drugs	drug	NNS	_	9	pobj	_
12	,	,	,	_	3	punct	_
13	and	and	CC	_	3	cc	_
14	argued	argue	VBD	p2=VBN|pb=argue.01	3	conj	_
15	it	it	PRP	_	16	nsubj	16:A0=PAG
16	has	have	VBZ	pb=have.03	14	ccomp	14:A1=PPT
17	no	no	DT	_	18	det	_
18	need	need	NN	_	16	dobj	16:A1=PPT
19	for	for	IN	_	18	prep	_
20	a	a	DT	_	21	det	_
21	deal	deal	NN	_	19	pobj	_
22	.	.	.	_	3	punct	_

